You are here: Home > Prescription(RX) Drugs > C > Calcium Chloride (Amphastar Pharmaceuticals, Inc.)

Name:Calcium Chloride
Manufacturer:Amphastar Pharmaceuticals, Inc.
Category:Prescription Marketed Drugs


CALCIUM CHLORIDE INJECTION, USP, 10%

CALCIUM CHLORIDE  - calcium chloride injection 
Amphastar Pharmaceuticals, Inc.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

CALCIUM CHLORIDE
INJECTION, USP, 10%

13.6 mEq (1 g) per 10 mL
100 mg (1.36 mEq)/ mL
Osmolarity approximately 2050 mOsmol/L

DESCRIPTION

Calcium Chloride Injection, USP, 10%, is a sterile aqueous solution containing, in each mL, 100 mg (1.36 mEq) calcium chloride. The pH of the solution may have been adjusted with hydrochloric acid and / or calcium hydroxide, when necessary. The air above the liquid in the individual containers has been displaced by flushing with nitrogen during the filling operation. The preparation contains no antimicrobial preservatives and is intended as a single-dose vial; once the unit is assembled and used, any remaining portion of the solution must be discarded with the entire unit.

Calcium Chloride, USP, contains two molecules of water of hydration and is chemically designated as CaCl2 • 2H20.

CLINICAL PHARMACOLOGY

Calcium is the fifth most abundant element in the body, the major fraction of which is found in the bony structure. Calcium plays important physiological roles; it is essential for the functional integrity of the nervous and muscular systems; it is necessary for normal cardiac function; and it is one of the factors involved in the mechanism of blood coagulation.

INDICATIONS AND USAGE

Calcium Chloride Injection, USP, 10% is indicated:

 
In the treatment of hypocalcemia in conditions requiring a prompt increase in plasma calcium levels (e.g., neonatal tetany and tetany due to parathyroid deficiency, vitamin D deficiency and alkalosis) and for prevention of hypocalcemia during exchange transfusions.
 
 
As adjunctive therapy in the management of acute symptoms in lead colic.
 
 
In the treatment of magnesium intoxication due to overdosage of magnesium sulfate.
 
 
In severe hyperkalemia, to combat deleterious effects on electrocardiographic (ECG) function, pending correction of the potassium level in the extracellular fluid.
 
 
In cardiac resuscitation, particularly after open heart surgery, when epinephrine fails to improve weak or ineffective myocardial contractions.

CONTRAINDICATIONS

Calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation.

WARNINGS

Calcium chloride should be injected into a large vein very slowly, as it may cause peripheral vasodilatation and a cutaneous burning sensation. A moderate fall in blood pressure due to vasodilatation may attend the injection. Since calcium chloride is an acidifying salt, it is usually undesirable in the treatment of hypocalcemia or renal insufficiency.

PRECAUTIONS

General

Calcium Chloride Injection, USP, 10% is irritating to veins and must not be injected into tissues, since severe necrosis and sloughing may occur. Great care should be taken to avoid extravasation or accidental injection into perivascular tissues.

Solutions should be warmed to body temperature. Injections should be made slowly through a small needle into a large vein to minimize venous irritation and avoid undesirable reactions. It is particularly important to prevent a high concentration of calcium from reaching the heart because of the danger of cardiac syncope. If injected into the ventricular cavity in cardiac resuscitation care must be taken to avoid injection into the myocardial tissue.

Drug Interactions

Because of the danger involved in the simultaneous use of calcium salts and drugs of the digitalis group, a digitalized patient should not receive an intravenous injection of a calcium compound unless the indications are clearly defined.

Calcium salts should not generally be mixed with carbonates, phosphates, sulfates or tartrates in parenteral admixtures.

ADVERSE REACTIONS

Rapid I.V. injection may cause the patient to complain of tingling sensations, a calcium taste, a sense of oppression or "heat wave."

Injections of calcium chloride are accompanied by peripheral vasodilation as well as a local "burning" sensation, and there may be a moderate fall in blood pressure.

DOSAGE AND ADMINISTRATION

FOR INTRACARDIAC OR INTRAVENOUS USE ONLY

Please note that the optional STICK-GARD® Safety Needle, featured with stock number 2004 is interchangeable with a standard needle.

INJECT SLOWLY

Calcium Chloride Injection, USP, 10%, is administered only by slow intravenous injection (not to exceed 1 mL/min) and / or in cardiac resuscitation, by injection into the ventricular cavity. It must not be injected into the myocardium.

The usual precautions for intravenous therapy should be observed. If time permits, the solution should be warmed to body temperature. The injection should be halted if the patient complains of any discomfort; it may be resumed when symptoms disappear. Following injection, the patient should remain recumbent for a short time.

INTRACARDIAC USE

For cardiac resuscitation, inject into the ventricular cavity, not into the heart muscle.

Usual Adult Dosage

200 to 800 mg (2 to 8 mL) when injected into the ventricular cavity.

Pediatric Dosage

0.2 mL/kg of body weight.

INTRAVENOUS USE

Hypocalcemic Disorders

Usual Adult Dosage

500 mg to 1 g (5 to 10 mL) at intervals of 1 to 3 days, depending on the response of the patient and / or results of serum calcium determinations. Repeated injections may be required because of rapid excretion of calcium.

Pediatric Dosage

0.2 mL /kg of body weight. Maximum 1-10 mL/day.

Magnesium Intoxication

Initial Adult Dose

500 mg (5 mL) administered promptly and the patient observed for signs of recovery before further doses are given.

Hyperkalemic ECG Disturbances of Cardiac Function

Dosage should be adjusted by constant monitoring of ECG changes during administration.

HOW SUPPLIED

CALCIUM CHLORIDE INJECTION, USP, 10%

In unit-use packages containing a MIN-I-JET® disposable syringe.

Stock No. 1004
(with 21 G. × 1 1/2" needle)
NDC 0548-1004-00 10 mL

In unit-use packages containing a disposable MIN-I-JET® Luer-Lock syringe with optional STICK-GARD® Safety Needle.

Stock No. 2004 NDC 0548-2004-00 10 mL

Twenty-five unit-use packages per carton.

Manufactured under U.S. Pat. No. 4,834,716, Reissue No. 33,617, STICK-GARD® Safety Needle.

In unit-use packages containing a Luer-Jet™ Luer-Lock Prefilled Syringe.

Stock No. 3304 NDC 0548-3304-00 10 mL

Ten unit-use packages per carton.

Syringe Assembly Directions

The MIN-I-JET® syringe with needle, illustrated below, is the basic unit upon which all the other syringe systems are built; slight adaptations and / or additional auxiliary parts create the other syringe systems. Assembly directions remain essentially the same.

USE ASEPTIC TECHNIQUE

Do not assemble until ready to use.

*
CAUTION: IMPROPER ENGAGING MAY CAUSE GLASS BREAKAGE AND SUBSEQUENT INJURY.
Figure Figure Figure
Remove protective caps. Align vial such that the injector needle is centered on the stopper. Thread vial into injector 3 half turns or until needle penetrates stopper.* DO NOT PUSH VIAL INTO INJECTOR; THIS MAY CAUSE MISALIGNMENT. Remove needle cap and expel air.

Store at controlled room temperature 15° to 30°C (59° to 86°F).

Rx Only

INTERNATIONAL MEDICATION SYSTEMS, LIMITED
So. El Monte, CA 91733, U.S.A.
An Amphastar Pharmaceuticals Company

Rev. 1-08

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

MIN-I-JET®
Prefilled Syringe

NDC 0548-1004-00
STOCK NO. 1004

Rx Only

CALCIUM CHLORIDE
INJ., USP, 10%
(100 mg/mL)
1.36 mEq/mL

1g
per
10 mL

FOR SLOW INTRAVENOUS USE ONLY

MIN-I-JET® 21 G. X 1 1/2" NEEDLE

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

FEATURING STICK-GARD®
18 G. SAFETY INJECTOR

NDC 0548-2004-00
STOCK NO. 2004

Rx Only

CALCIUM CHLORIDE
INJ., USP, 10%
1.36 mEq/mL
(100 mg/mL)

13.6 mEq
(1 g)
per
10 mL

FOR SLOW INTRAVENOUS USE ONLY

STICK-GARD® PREFILLED SYRINGE

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

Luer-Lock Prefilled Syringe

NDC 0548-3304-00
STOCK NO. 3304

Rx Only

CALCIUM CHLORIDE
INJ., USP, 10%
1.36 mEq/ mL
(100 mg/ mL)

13.6 mEq
(1 g)
per
10 mL

FOR SLOW INTRAVENOUS USE

LUER-JET™ LUER-LOCK PREFILLED SYRINGE

PRINCIPAL DISPLAY PANEL - 10 mL Syringe Carton

CALCIUM CHLORIDE 
calcium chloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0548-1004
Route of Administration PARENTERAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Calcium Chloride (Calcium Cation) Calcium Chloride 100 mg  in 1 mL
Product Characteristics
Color      Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0548-1004-00 25 SYRINGE ( SYRINGE) in 1 CARTON contains a SYRINGE
1 10 mL in 1 SYRINGE This package is contained within the CARTON (0548-1004-00)

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 05/01/1973 12/31/2009

CALCIUM CHLORIDE 
calcium chloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0548-2004
Route of Administration PARENTERAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Calcium Chloride (Calcium Cation) Calcium Chloride 100 mg  in 1 mL
Product Characteristics
Color      Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0548-2004-00 25 SYRINGE ( SYRINGE) in 1 CARTON contains a SYRINGE
1 10 mL in 1 SYRINGE This package is contained within the CARTON (0548-2004-00)

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 01/02/1990 12/31/2009

CALCIUM CHLORIDE 
calcium chloride injection
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0548-3304
Route of Administration PARENTERAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Calcium Chloride (Calcium Cation) Calcium Chloride 100 mg  in 1 mL
Product Characteristics
Color      Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:0548-3304-00 10 SYRINGE ( SYRINGE) in 1 CARTON contains a SYRINGE
1 10 mL in 1 SYRINGE This package is contained within the CARTON (0548-3304-00)

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Unapproved drug other 06/01/2000

Labeler - Amphastar Pharmaceuticals, Inc. (024736733)

Revised: 09/2010 Amphastar Pharmaceuticals, Inc.



Source: http://dailymed.nlm.nih.gov
Reproduced with permission of U.S. National Library of Medicine


Copyright © 2017 Drugsdb.eu by Dionisios Fentas || Terms of Use

Loading

Prescription Marketed Drugs Alphabetically
A| B| C| D| E| F| G| H| I| J| K| L| M| N| O| P| Q| R| S| T| U| V| W| X| Y| Z| 0-9

Categories:
Prescription(RX) Drugs
Over-the-counter (OTC) Drugs
Homeopathic Drugs
Animal Drugs
Feedback